• 2025.01.16Timely Disclosure
  Prompt announcement of the result of the clinical performance test for the artificial intelligence(113KB)
• 2025.01.09Timely Disclosure
  Announcement of the results of the Phase I clinical trial with ET-02 (Active Ingredient RS5441) for the for the treatment of androgenetic alopecia (AGA) and age-related hair loss at Eirion Therapeutics, Inc., USA(131KB)
• 2025.01.06Timely Disclosure
  Announcement of approval by the Institutional Review Board of Tohoku University for Phase III trial of drug for the treatment of malignant melanoma(178KB)
• 2024.12.26Timely Disclosure
  Announcement of completion to enroll the planned sample size in the investigator-initiated Phase II clinical trial with a PAI-1 inhibitor RS5614 in systemic sclerosis (scleroderma)-associated interstitial lung disease (SSc-ILD)(156KB)
• 2024.12.06Timely Disclosure
  Notice of Revision of Full-Year Earnings Forecasts for the Fiscal Year Ending March , 2025(156KB)

IR News List